This competition aims to honour those with exceptional talent within the medical and scientific industry, by offering a platform for candidates to share best practice and prove they’ve got the skills to be successful.
Milestone Pharmaceuticals announced positive data from its Phase 2 NODE-1 trial evaluating etripamil, for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT), a potentially debilitating cardiac arrhythmia.